The team will develop and validate a large animal model of cardiac arrest with resultant severe brain injury to translate new neuroprotective therapies.
Read MoreThe Weil Institute inverviews Dr. Takahiro Nakashima, winner of the American Heart Association’s Max Harry Weil Award for Resuscitation Science.
Read MoreThe result of a major multi-departmental and multi-school collaboration, the investment will support the Weil Institute’s unique preclinical critical care lab to advance translational research in critical care over the next 5 years.
Read MoreThe Weil Institute Pre-Clinical Critical Care Laboratory (PC3L) is collaborating with medical device maker Abiomed, Inc. to examine the potential of using Abiomed Impella CP® left ventricular assist device as a resuscitative strategy for sudden cardiac arrest.
Read MoreIn the seven years since its founding, MCIRCC has collaborated with the Office of Technology transfer to spin out eight companies and licensed 14 products that are making positive impacts on patients in the critical care setting.
Read MoreAmid growing federal concerns regarding "foreign influence" on research activity, some federal agencies have issued statements emphasizing the need for increased transparency with respect to international collaborations. Failure to comply could jeopardize the ability of faculty and the university to receive federal support for research.
Read MoreAmerican Heart Association funding will allow Michigan Medicine to establish a leading research and training program, housed at MCIRCC, with a focus on preventing brain damage caused by out-of-hospital cardiac arrest.
Read MoreNorthwestern University, University of Michigan, University of Washington and Vanderbilt University Medical Center leading novel studies in newest American Heart Association Strategically Focused Research Network
Read More